Towards patient-specific prediction of conduction abnormalities induced by transcatheter aortic valve implantation: a combined mechanistic modelling and machine learning approach.

Conduction abnormalities Digital twin Machine learning Mechanistic modelling TAVI

Journal

European heart journal. Digital health
ISSN: 2634-3916
Titre abrégé: Eur Heart J Digit Health
Pays: England
ID NLM: 101778323

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 10 03 2021
revised: 12 05 2021
entrez: 30 1 2023
pubmed: 20 8 2021
medline: 20 8 2021
Statut: epublish

Résumé

Post-procedure conduction abnormalities (CA) remain a common complication of transcatheter aortic valve implantation (TAVI), highlighting the need for personalized prediction models. We used machine learning (ML), integrating statistical and mechanistic modelling to provide a patient-specific estimation of the probability of developing CA after TAVI. The cohort consisted of 151 patients with normal conduction and no pacemaker at baseline who underwent TAVI in nine European centres. Devices included CoreValve, Evolut R, Evolut PRO, and Lotus. Preoperative multi-slice computed tomography was performed. Virtual valve implantation with patient-specific computer modelling and simulation (CM&S) allowed calculation of valve-induced contact pressure on the anatomy. The primary composite outcome was new onset left or right bundle branch block or permanent pacemaker implantation (PPI) before discharge. A supervised ML approach was applied with eight models predicting CA based on anatomical, procedural and mechanistic data. CA occurred in 59% of patients ( ML, integrating statistical and mechanistic modelling, achieved an accurate prediction of CA after TAVI. This study demonstrates the potential of a synergetic approach for personalizing procedure planning, allowing selection of the optimal device and implantation strategy, avoiding new CA and/or PPI.

Identifiants

pubmed: 36713106
doi: 10.1093/ehjdh/ztab063
pii: ztab063
pmc: PMC9708019
doi:

Types de publication

Journal Article

Langues

eng

Pagination

606-615

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

JACC Cardiovasc Interv. 2015 Aug 17;8(9):1218-1228
pubmed: 26292585
Eur Heart J. 2020 Dec 21;41(48):4556-4564
pubmed: 32128588
N Engl J Med. 2019 May 2;380(18):1695-1705
pubmed: 30883058
Front Physiol. 2018 Mar 13;9:213
pubmed: 29593570
Circ Cardiovasc Imaging. 2015 Sep;8(9):e003744
pubmed: 26338877
Circ Cardiovasc Interv. 2018 Feb;11(2):e005344
pubmed: 29386188
Circulation. 2017 Sep 12;136(11):1049-1069
pubmed: 28893961
Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):72-80
pubmed: 32819849
Eur Heart J. 2017 Jun 14;38(23):1805-1814
pubmed: 27436868
J Am Coll Cardiol. 2019 Mar 26;73(11):1317-1335
pubmed: 30898208
N Engl J Med. 2017 Apr 6;376(14):1321-1331
pubmed: 28304219
N Engl J Med. 2019 May 2;380(18):1706-1715
pubmed: 30883053
N Engl J Med. 2010 Oct 21;363(17):1597-607
pubmed: 20961243
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
J Cardiovasc Transl Res. 2019 Oct;12(5):435-446
pubmed: 31444672
Drug Discov Today. 2016 Jun;21(6):924-38
pubmed: 26891981
JACC Cardiovasc Interv. 2019 Sep 23;12(18):1796-1807
pubmed: 31473236
Clin Res Cardiol. 2021 Mar;110(3):343-356
pubmed: 32583062
Circulation. 2020 Jan 28;141(4):260-268
pubmed: 31736332
Circ Cardiovasc Imaging. 2019 Oct;12(10):e009178
pubmed: 31594409
JACC Cardiovasc Interv. 2018 Jan 22;11(2):160-168
pubmed: 29348010
Front Cardiovasc Med. 2018 Jul 03;5:85
pubmed: 30018969
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
J Am Coll Cardiol. 2014 Jul 15;64(2):129-40
pubmed: 25011716

Auteurs

Valeria Galli (V)

FEops NV, Technologiepark 122, 9052 Ghent, Belgium.

Filip Loncaric (F)

Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Carrer del Rosselló, 149, 08036, Barcelona, Spain.

Giorgia Rocatello (G)

FEops NV, Technologiepark 122, 9052 Ghent, Belgium.

Patricio Astudillo (P)

FEops NV, Technologiepark 122, 9052 Ghent, Belgium.

Laura Sanchis (L)

Cardiovascular Institute, Hospital Clínic and Universitat de Barcelona, C. de Villarroel, 170, 08036 Barcelona, Spain.

Ander Regueiro (A)

Cardiovascular Institute, Hospital Clínic and Universitat de Barcelona, C. de Villarroel, 170, 08036 Barcelona, Spain.

Ole De Backer (O)

Department of Cardiology, Rigshospitalet University Hospital, Blegdamsvej 9, 2100 København, Denmark.

Martin Swaans (M)

Department of Cardiology, St. Antonius Ziekenhuis, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.

Johan Bosmans (J)

Department of Cardiology, University Hospital Antwerp, Drie Eikenstraat 655, 2650 Edegem, Antwerp, Belgium.

Joana Maria Ribeiro (JM)

Department of Cardiology, Erasmus MC, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

Pablo Lamata (P)

Department of Biomedical Engineering, King's College London, Strand, London WC2R 2LS, UK.

Marta Sitges (M)

Institute of Biomedical Research August Pi Sunyer (IDIBAPS), Carrer del Rosselló, 149, 08036, Barcelona, Spain.
Cardiovascular Institute, Hospital Clínic and Universitat de Barcelona, C. de Villarroel, 170, 08036 Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, Planta 0 28029 Madrid, Spain.

Peter de Jaegere (P)

Department of Cardiology, Erasmus MC, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

Peter Mortier (P)

FEops NV, Technologiepark 122, 9052 Ghent, Belgium.

Classifications MeSH